Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. CorMedix Inc shares valued at $14,985 were purchased by Mistry Erin on Oct 31 ’24. At $9.99 per share, Mistry Erin acquired 1,500 shares. The insider’s holdings grew to 52,011 shares worth approximately $0.56 million following the completion of this transaction.
Also, Hurlburt Elizabeth sold 140,027 shares, netting a total of over 1,565,670 in proceeds. Following the sale of shares at $11.18 each, the insider now holds 45,397 shares.
Before that, Hurlburt Elizabeth had added 140,027 shares to its account. In a trade valued at $1,556,416, the Officer bought CorMedix Inc shares for $11.12 each.
As published in their initiating research note from Rodman & Renshaw on August 26, 2024, CorMedix Inc [CRMD] has been a Buy and the price target has been revised to $13. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in early August. As of February 17, 2021, Needham has initiated its “Buy” rating for CRMD. Earlier on September 29, 2020, JMP Securities initiated its rating. Their recommendation was “a Mkt outperform” for CRMD stock.
Analyzing CRMD Stock Performance
During the last five days, there has been a surge of approximately 33.46%. Over the course of the year, CorMedix Inc shares have jumped approximately 33.46%. Shares of the company reached a 52-week high of $11.00 on 01/08/25 and a 52-week low of $7.91 on 01/06/25. A 50-day SMA is recorded $9.79, while a 200-day SMA reached $6.84. Nevertheless, trading volume fell to 2.38 million shares from 5.66 million shares the previous day.
Support And Resistance Levels for CorMedix Inc (CRMD)
According to the 24-hour chart, there is a support level at 10.28, which, if violated, would cause prices to drop to 9.75. In the upper region, resistance lies at 11.17. The next price resistance is at 11.53. RSI (Relative Strength Index) is 67.06 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.06, which suggests the price will increase in the coming days. Percent R is at 5.92%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
